A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047
Clinical trial NCT03160339 · TERMINATED
Trial details
- NCT number
- NCT03160339
- Sponsor
- Emergent BioSolutions
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2017-11-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.